Delisting / Deal May Not Happen!13 Dec 2022 19:34
Reading RNS again, this deal is conditional to a lot of things including shareholder approval at GMs in both companies, courts and placement. GMs in both companies is in the new year no confirmed date:
The Acquisition is conditional, inter alia, upon the Arrangement being approved by the Court and the Bioasis Securityholders, the Private Placement and the approval by Existing Shareholders of the Resolutions at the Company's General Meeting, including the cancellation of admission to trading of the Ordinary Shares on AIM, expected to be held in Q1 2023.
With effect from the AIM Cancellation, Sijmen de Vries will resign as a Director of the Company and Deborah Rathjen and Mario Saltarelli will be appointed as Directors of the Company.